J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers et al., Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012, Int. J. Cancer, vol.136, pp.359-386, 2015.

M. Cesari, F. Cerullo, V. Zamboni, R. Di-palma, G. Scambia et al., Functional status and mortality in older women with gynecological cancer, J. Gerontol. A Biol. Sci. Med. Sci, vol.68, pp.1129-1133, 2013.

G. D. Aletti, S. C. Dowdy, K. C. Podratz, and W. A. Cliby, Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer, Am. J. Obstet. Gynecol, vol.197, pp.676-677, 2007.

J. D. Wright, L. Chen, A. I. Tergas, S. Patankar, W. M. Burke et al., Trends in relative survival for ovarian cancer from, Obstet. Gynecol, vol.125, pp.1345-1352, 1975.

L. A. Ries, Ovarian cancer. Survival and treatment differences by age, Cancer, vol.71, pp.524-529, 1993.

N. Howlader, L. A. Ries, A. B. Mariotto, M. E. Reichman, J. Ruhl et al., Improved estimates of cancer-specific survival rates from population-based data, J. Natl. Cancer Inst, vol.102, pp.1584-1598, 2010.

R. E. Bristow, R. S. Tomacruz, D. K. Armstrong, E. L. Trimble, and F. J. Montz, Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis, J. Clin. Oncol, vol.20, pp.1248-1259, 2002.

K. N. Moore, M. S. Reid, D. N. Fong, T. K. Myers, L. M. Landrum et al., Ovarian cancer in the octogenarian: Does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply?, Gynecol. Oncol, vol.110, pp.133-139, 2008.

D. S. Alberts, S. Dahlberg, S. J. Green, D. Garcia, E. V. Hannigan et al., Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and IV ovarian cancer. A Southwest Oncology Group study, Cancer, vol.71, pp.618-627, 1993.

R. Yancik, L. G. Ries, and J. W. Yates, Ovarian cancer in the elderly: An analysis of surveillance, epidemiology, and end results program data, Am. J. Obstet. Gynecol, vol.154, pp.639-647, 1986.

R. D. Hightower, H. N. Nguyen, H. E. Averette, W. Hoskins, T. Harrison et al., National survey of ovarian carcinoma. IV: Patterns of care and related survival for older patients, Cancer, vol.73, pp.377-383, 1994.

T. P. Díaz-montes, M. L. Zahurak, I. I. Giuntoli, R. L. Gardner, G. J. Gordon et al., Surgical care of elderly women with ovarian cancer: A population-based perspective, Gynecol. Oncol, vol.99, pp.352-357, 2005.

N. G. Cloven, A. Manetta, M. L. Berman, M. F. Kohler, and P. J. Disaia, Management of ovarian cancer in patients older than 80 years of Age, Gynecol. Oncol, vol.73, pp.137-139, 1999.

T. Thigpen, M. F. Brady, G. A. Omura, W. T. Creasman, W. P. Mcguire et al., Age as a prognostic factor in ovarian carcinoma. The Gynecologic Oncology Group experience, Cancer, vol.71, pp.606-614, 1993.

J. H. Lewis, M. L. Kilgore, D. P. Goldman, E. L. Trimble, R. Kaplan et al., Participation of patients 65 years of age or older in cancer clinical trials, J. Clin. Oncol. Oncol, vol.21, pp.1383-1389, 2003.

M. Markman, J. L. Lewis, . Jr, P. Saigo, T. Hakes et al., Epithelial ovarian cancer in the elderly. The Memorial Sloan-Kettering Cancer Center experience, Cancer, vol.71, pp.634-637, 1993.

B. K. Edwards, H. L. Howe, L. A. Ries, M. J. Thun, H. M. Rosenberg et al., Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U, vol.94, pp.2766-2792, 2002.

C. E. Hightower, B. J. Riedel, B. W. Feig, G. S. Morris, J. E. Ensor et al., A pilot study evaluating predictors of postoperative outcomes after major abdominal surgery: Physiological capacity compared with the ASA physical status classification system, Br. J. Anaesth, vol.104, pp.465-471, 2010.

A. K. Hohn, J. Einenkel, C. Wittekind, and L. C. Horn, New FIGO classification of ovarian, fallopian tube and primary peritoneal cancer, Pathologe, vol.35, pp.322-326, 2014.

M. Luyckx, E. Leblanc, T. Filleron, P. Morice, E. Darai et al., Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: A retrospective French multicentric study, Int. J. Gynecol. Cancer, vol.22, pp.1337-1343, 2012.

D. Dindo, N. Demartines, and P. A. Clavien, Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey, Ann. Surg, vol.240, pp.205-213, 2004.

D. Uyar, H. E. Frasure, M. Markman, and V. E. Von-gruenigen, Treatment patterns by decade of life in elderly women (> or =70 years of age) with ovarian cancer, Gynecol. Oncol. Oncol, vol.98, pp.403-408, 2005.

V. Sundararajan, D. Hershman, V. R. Grann, J. S. Jacobson, and A. I. Neugut, Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: A population-based study, J. Clin. Oncol, vol.20, pp.173-178, 2002.

R. Yancik, T. D. Moore, G. Martin, G. I. Obrams, and E. Reed, Older women as the focus for research and treatment of ovarian cancer. An overview for the National Institute on Aging, National Cancer Institute, Cancer, vol.71, pp.514-516, 1993.

W. Kuhn, Clinical trials in elderly ovarian cancer patients-Does it make sense? Onkologie, vol.35, pp.73-74, 2012.

L. Tortorella, G. Vizzielli, D. Fusco, W. C. Cho, R. Bernabei et al., Ovarian cancer management in the oldest old: Improving outcomes and tailoring treatments, Aging Dis, vol.8, pp.677-684, 2017.

P. Shenoy and A. Harugeri, Elderly patients' participation in clinical trials, Perspect Clin. Res, vol.6, pp.184-189, 2015.

J. L. Warren, L. C. Harlan, E. L. Trimble, J. Stevens, M. Grimes et al., Trends in the receipt of guideline care and survival for women with ovarian cancer: A population-based study, Gynecol. Oncol, vol.145, pp.486-492, 2017.

D. M. Gershenson, M. F. Mitchell, N. Atkinson, E. G. Silva, T. W. Burke et al., Age contrasts in patients with advanced epithelial ovarian cancer. The M.D. Anderson Cancer Center experience, Cancer, vol.71, pp.638-643, 1993.

L. F. Hutchins, J. M. Unger, J. J. Crowley, C. A. Coltman, and K. S. Albain, Underrepresentation of patients 65 years of age or older in cancer-treatment trials, N. Engl. J. Med, vol.341, pp.2061-2067, 1999.

K. W. Yee, J. L. Pater, L. Pho, B. Zee, and L. L. Siu, Enrollment of older patients in cancer treatment trials in Canada: Why is age a barrier?, J. Clin. Oncol, vol.21, pp.1618-1623, 2003.

E. L. Trimble, C. L. Carter, D. Cain, B. Freidlin, R. S. Ungerleider et al., Representation of older patients in cancer treatment trials, Cancer, vol.74, pp.2208-2214, 1994.

A. Kumar, C. L. Langstraat, S. R. Dejong, M. E. Mcgree, J. N. Bakkum-gamez et al., Functional not chronologic age: Frailty index predicts outcomes in advanced ovarian cancer, Gynecol. Oncol, vol.147, pp.104-109, 2017.

A. Ferrero, L. Fuso, E. Tripodi, R. Tana, A. Daniele et al., Ovarian cancer in elderly patients: Patterns of care and treatment outcomes according to age and modified frailty index, Int. J. Gynecol. Cancer, vol.27, pp.1863-1871, 2017.

M. Ceccaroni, G. D'agostino, G. Ferrandina, A. Gadducci, G. Di-vagno et al., Gynecological malignancies in elderly patients: Is age 70 a limit to standard-dose chemotherapy? An Italian retrospective toxicity multicentric study, Gynecol. Oncol. Oncol, vol.85, pp.445-450, 2002.

J. Villella and E. Chalas, Optimising treatment of elderly patients with ovarian cancer: Improving their enrollment in clinical trials, Drugs Aging, vol.22, pp.95-100, 2005.

I. Bruchim, M. Altaras, and A. Fishman, Age contrasts in clinical characteristics and pattern of care in patients with epithelial ovarian cancer, Gynecol. Oncol. Oncol, vol.86, pp.274-278, 2002.

E. L. Eisenhauer, W. P. Tew, D. A. Levine, S. M. Lichtman, C. L. Brown et al., Response and outcomes in elderly patients with stages IIIC-IV ovarian cancer receiving platinum-taxane chemotherapy, Gynecol. Oncol, vol.106, pp.381-387, 2007.

D. Hershman, A. T. Fleischauer, J. S. Jacobson, V. R. Grann, V. Sundararajan et al., Patterns and outcomes of chemotherapy for elderly patients with stage II ovarian cancer: A population-based study, Gynecol. Oncol, vol.92, pp.293-299, 2004.

F. Hilpert, A. Bois, E. R. Greimel, J. Hedderich, G. Krause et al., Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged > or =70 years with advanced ovarian cancer-A study by the AGO OVAR Germany, Ann. Oncol, vol.18, pp.282-287, 2007.

K. M. Fairfield, K. Murray, F. L. Lucas, H. R. Wierman, C. C. Earle et al., Completion of adjuvant chemotherapy and use of health services for older women with epithelial ovarian cancer, J. Clin. Oncol, vol.29, pp.3921-3926, 2011.

G. Amadio, C. Marchetti, E. R. Villani, D. Fusco, F. Stollagli et al., ToleRability of BevacizUmab in elderly ovarian cancer patients (TURBO study): A case-control study of a real-life experience, J. Gynecol. Oncol, vol.31, 2020.

T. J. Perren, A. M. Swart, J. Pfisterer, J. A. Ledermann, E. Pujade-lauraine et al., A phase 3 trial of bevacizumab in ovarian cancer, N. Engl. J. Med, vol.365, pp.2484-2496, 2011.

R. Yancik, Cancer burden in the aged: An epidemiologic and demographic overview, Cancer, vol.80, pp.1273-1283, 1997.

E. Chereau, M. Ballester, F. Selle, R. Rouzier, and E. Darai, Ovarian cancer in the elderly: Impact of surgery on morbidity and survival, Eur. J. Surg. Oncol, vol.37, pp.537-542, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00696626

H. H. Alphs, M. L. Zahurak, R. E. Bristow, and T. P. Diaz-montes, Predictors of surgical outcome and survival among elderly women diagnosed with ovarian and primary peritoneal cancer, Gynecol. Oncol, vol.103, pp.1048-1053, 2006.

H. Woopen, G. Inci, R. Richter, R. Chekerov, F. Ismaeel et al., Elderly ovarian cancer patients: An individual participant data meta-analysis of the North-Eastern German Society of Gynecological Oncology (NOGGO), Eur. J. Cancer, vol.60, pp.101-106, 2016.

R. E. Bristow, M. L. Zahurak, T. P. Diaz-montes, R. L. Giuntoli, and D. K. Armstrong, Impact of surgeon and hospital ovarian cancer surgical case volume on in-hospital mortality and related short-term outcomes, Gynecol. Oncol, vol.115, pp.334-338, 2009.

V. Lavoue, C. Huchon, C. Akladios, P. Alfonsi, N. Bakrin et al., Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Long text of the Joint French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa. Part 1: Diagnostic exploration and staging, surgery, perioperative care, and pathology, J. Gynecol. Obstet. Hum. Reprod, vol.48, pp.369-378, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02088076

V. Lavoue, C. Huchon, C. Akladios, P. Alfonsi, N. Bakrin et al., Management of epithelial cancer of the ovary, fallopian tube, primary peritoneum. Long text of the joint French clinical practice guidelines issued by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY, endorsed by INCa. (Part 2: Systemic, intraperitoneal treatment, elderly patients, fertility preservation, follow-up), J. Gynecol. Obstet. Hum. Reprod, vol.48, pp.379-386, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02088076

P. Harter, J. Sehouli, D. Lorusso, A. Reuss, I. Vergote et al., A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms, N. Engl. J. Med, vol.380, pp.822-832, 2019.

K. Moore, N. Colombo, G. Scambia, B. G. Kim, A. Oaknin et al., Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer, N. Engl. J. Med, vol.379, pp.2495-2505, 2018.

W. J. Van-driel, S. N. Koole, K. Sikorska, J. H. Schagen-van-leeuwen, H. W. Schreuder et al., Hyperthermic intraperitoneal chemotherapy in ovarian cancer, N. Engl. J. Med, vol.378, pp.230-240, 2018.